A. Jou

D. Podzamczer, B. Clotet, J. Miro, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir

B. Clotet, E. Ballana, R. Badia, 2017, Antimicrobial Agents and Chemotherapy.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.

R. Paredes, B. Clotet, L. Ruiz, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients

D. Podzamczer, C. Tural, M. Crespo, 2010, AIDS.

Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection

W. Rozenbaum, N. Clumeck, F. Castelli, 1996, AIDS.

High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response.

R. Paredes, B. Clotet, L. Ruiz, 1999, Journal of acquired immune deficiency syndromes.

Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with

M. Juan, B. Clotet, J. Martinez-Picado, 1999, The Journal of infectious diseases.

Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.

B. Clotet, C. Tural, I. Ojanguren, 2012, AIDS research and human retroviruses.

Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review

D. Podzamczer, J. Miro, D. Giralt, 2021, BMC Public Health.

Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+ T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy.

B. Clotet, J. Martinez-Picado, L. Montaner, 2016, The Journal of infectious diseases.

Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy.

B. Clotet, L. Ruiz, J. Blanco, 1999, AIDS.

Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.

D. Podzamczer, B. Clotet, J. Romeu, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.

R. Paredes, L. Ruiz, J. Romeu, 1999, Antiviral therapy.

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.

A. Cruceta, J. Mallolas, M. Laguno, 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Incidence of Hepatocellular Carcinoma in HIV-Infected Patients With Cirrhosis: A Prospective Study

J. Arribas, C. Quereda, J. Miró, 2014, Journal of acquired immune deficiency syndromes.

Pulse Wave Velocity as Index of Arterial Stiffness in HIV-Infected Patients Compared With a Healthy Population

B. Clotet, E. Negredo, J. Moltó, 2014, Journal of acquired immune deficiency syndromes.

Progression of liver fibrosis in HIV/hepatitis C virus‐coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline

B. Clotet, C. Tural, I. Ojanguren, 2014, HIV medicine.

Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV‐Coinfected Patients in Clinical Practice

B. Clotet, C. Tural, N. Pérez-Álvarez, 2018, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Changing utilization of Stavudine (d4T) in HIV‐positive people in 2006–2013 in the EuroSIDA study

J. Nielsen, C. Leen, P. Vanhems, 2015, HIV medicine.

Prospective Randomized Two‐Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long‐Term Adherence to Highly Active Antiretroviral Therapy

B Clotet, B. Clotet, L. Ruiz, 2000, Journal of acquired immune deficiency syndromes.

Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.

J. Mallolas, C. Quereda, F. Pulido, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

R. Paredes, B. Clotet, J. Romeu, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

C. Tural, M. Díaz-Menéndez, J. Macías, 2014, AIDS.

Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

A. Mocroft, A. Blaxhult, J. Lundgren, 2018, HIV medicine.

Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects.

D. Podzamczer, B. Clotet, G. Sirera, 2004, Vaccine.